WESTBOROUGH, Mass. – Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical solutions and high performance micro-displays for defense, enterprise, consumer and medical products, today announced it has received an initial production order for the CR3 wearable surgical monitor from HMDmd Inc (HMDmd).
The CR3 is a head-mounted display (“HMD”) system that is the culmination of a multi-year development program by Kopin and HMDmd to produce a medical-grade wearable monitor that meets the exacting needs of surgeons and supporting clinical personnel. The CR3 provides full-HD resolution 3-D imagery in a lightweight, ergonomic package and is 4K video compatible. The CR3 is configured for use with 2-D and 3-D endoscopes and operating microscopes/exoscopes and is plug-in compatible with products produced by major surgical systems companies.
“Kopin’s CR3 head-mounted monitor is a truly ground-breaking wearable that is purpose-built for surgeons and builds upon Kopin’s extensive experience with high-performance head-mounted military pilot, soldier, and training microdisplay systems,” said Bill Maffucci, Kopin’s Senior Vice President of Business Development and Strategy. “The CR3 incorporates advanced design features that satisfy critical human visual system and ergonomic factors, resulting in an HMD with outstanding 3D imagery that is comfortable to view and wear over long-duration procedures.”
The CR3 enables surgeons to maintain a direct view of the surgical field while also being able to easily access critical information, such as live video feeds from surgical instruments and diagnostic images, by simply glancing up to see needed information on the head-worn display system, as opposed to constantly moving their head up to see a monitor and then down to see the patient.
John Lyon, CEO of HMDmd, said, “The specification of CR3 and guiding principles of its development have been to provide surgeons with high-resolution 2D and 3D video imagery and superior ergonomics while performing surgery. The CR3 provides a functionality leap from the current solution, which involves looking away at a remotely positioned conventional video monitor. In the development process Kopin’s deep experience in the design and production of mission-critical, head-mounted microdisplay systems for the military proved critical. We anticipate that our focus on superior ergonomics will be particularly beneficial for surgical use-cases in microscopy, minimally invasive surgery, digital and robotic surgery and interventional medicine. The feedback from surgeons and surgical equipment manufacturers has been very positive.”
Kopin Corporation is a leading developer and provider of innovative display and optical technologies sold as critical components and subassemblies for defense, industrial and consumer products. Kopin’s technology portfolio includes ultra-small Active-Matrix Liquid Crystal displays (AMLCD), Liquid Crystal on Silicon (LCOS) displays and Organic Light Emitting Diode (OLED) displays, a variety of optics, and low-power ASICs. For more information, please visit Kopin’s website at www.kopin.com.
About HMDmd, Inc.
HMDmd, based in Solana Beach, CA, is entirely focused on providing high-performance wearable display systems for surgery, interventional medicine and other medical specialties and applications. The Company’s business model is to provide customized, medical grade headsets to be integrated as the display component of proprietary systems commercialized by strategic distribution partners. For further information see www.hmdmd.com or contact John Lyon, CEO: firstname.lastname@example.org.
Statements in this press release may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are subject to the safe harbor created by such sections. Words such as “expects,” “believes,” “can,” “will,” “estimates,” and variations of such words and similar expressions, and the negatives thereof, are intended to identify such forward-looking statements. We caution readers not to place undue reliance on any such “forward-looking statements,” which speak only as of the date made, and advise readers that these forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties, estimates, and assumptions by us that are difficult to predict. These forward-looking statements may include statements with respect to our expectation that our focus on superior ergonomics will be particularly beneficial for surgical use-cases in microscopy, minimally invasive surgery, digital and robotic surgery and interventional medicine. Various factors, some of which are beyond our control, could cause actual results to differ materially from those expressed in, or implied by, such forward-looking statements. All such forward-looking statements, whether written or oral, and whether made by us or on our behalf, are expressly qualified by these cautionary statements and any other cautionary statements that may accompany the forward-looking statements. In addition, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release, except as may otherwise be required by the federal securities laws. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management’s expectations are described in Part I, Item 1A. Risk Factors; Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations; and other parts of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, or as updated from time to time our Securities and Exchange Commission filings.
Bill Maffucci, 508-870-5959
SVP of Business Development and Strategy,
Richard Sneider, 508-870-5959
Treasurer and Chief Financial Officer
Brian M. Prenoveau, CFA, 561 489 5315
MZ Group – MZ North America
John Lyon, 760-518-1132